COGNIZANT TECHNOLOGY SOLUTIONS CORP
CTSHAPI behind this page
CTSH Q4 2025 request
Playground key active
/api/financials?ticker=CTSH&year=2025&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue | 5,333 | 5,082 | +4.9% |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 3,534 | 3,297 | +7.2% |
| Selling, General & Administrative | 806 | 844 | -4.5% |
| Depreciation And Amortization | 140 | 141 | -0.7% |
| Operating Income | 853 | 751 | +13.6% |
Show Business Segments breakouts |
|||
| Communications, Media and Technology · Operating Segments | 114 | 112 | +1.8% |
| Financial Services · Operating Segments | 310 | 126 | +146.0% |
| Health Sciences · Operating Segments | 259 | 406 | -36.2% |
| Products and Resources · Operating Segments | 204 | 210 | -2.9% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 887 | 854 | +3.9% |
| Investment Income Interest And Dividend | 27 | 28 | -3.6% |
| Interest Expense | -8 | -19 | +57.9% |
| Foreign Currency Transaction Gain Loss Before Tax | 5 | -18 | +127.8% |
| Non-Operating Income (Expense) | 25 | -11 | +327.3% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 878 | 740 | +18.6% |
| Income Tax Expense (Benefit) | -235 | -199 | -18.1% |
| Income Loss From Equity Method Investments | 5 | 5 | 0.0% |
| Net Income | 648 | 546 | +18.7% |
| EPS (Basic) | 1.35 | 1.11 | +21.6% |
| EPS (Diluted) | 1.34 | 1.1 | +21.8% |
| Wtd Avg Shares (Basic) | -3 | -1 | -200.0% |
| Wtd Avg Shares (Diluted) | -2 | 0 | — |
| Revenue | 5,333 | 5,082 | +4.9% |
Show Product Lines breakouts |
|||
| Consulting And Technology Services [Member] | 3,424 | 3,237 | +5.8% |
| Consulting And Technology Services [Member] · Financial Services | 1,128 | 997 | +13.1% |
| Consulting And Technology Services [Member] · Health Sciences | 944 | 896 | +5.4% |
| Consulting And Technology Services [Member] · Products and Resources | 911 | 896 | +1.7% |
| Outsourcing Services [Member] | 1,909 | 1,845 | +3.5% |
| Outsourcing Services [Member] · Financial Services | 458 | 438 | +4.6% |
| Outsourcing Services [Member] · Health Sciences | 677 | 645 | +5.0% |
| Outsourcing Services [Member] · Products and Resources | 407 | 399 | +2.0% |
Show Business Segments breakouts |
|||
| Financial Services | 1,586 | 1,435 | +10.5% |
| Financial Services · Europe | 334 | 300 | +11.3% |
| Financial Services · Europe, excluding United Kingdom [Member] | 169 | 156 | +8.3% |
| Financial Services · Fixed Price Contract | 776 | 623 | +24.6% |
| Financial Services · GB | 165 | 144 | +14.6% |
| Financial Services · North America | 1,126 | 1,011 | +11.4% |
| Financial Services · Rest of World [Member] | 126 | 124 | +1.6% |
| Financial Services · Time And Materials Contract | 756 | 767 | -1.4% |
| Financial Services · Transaction Or Volume-Based [Member] | 54 | 45 | +20.0% |
| Health Sciences | 1,621 | 1,541 | +5.2% |
| Health Sciences · Europe | 225 | 194 | +16.0% |
| Health Sciences · Europe, excluding United Kingdom [Member] | 167 | 146 | +14.4% |
| Health Sciences · Fixed Price Contract | 817 | 767 | +6.5% |
| Health Sciences · GB | 58 | 48 | +20.8% |
| Health Sciences · North America | 1,352 | 1,316 | +2.7% |
| Health Sciences · Rest of World [Member] | 44 | 31 | +41.9% |
| Health Sciences · Time And Materials Contract | 496 | 482 | +2.9% |
| Health Sciences · Transaction Or Volume-Based [Member] | 308 | 292 | +5.5% |
| Products and Resources | 1,318 | 1,295 | +1.8% |
| Products and Resources · Europe | 314 | 301 | +4.3% |
| Products and Resources · Europe, excluding United Kingdom [Member] | 171 | 158 | +8.2% |
| Products and Resources · Fixed Price Contract | 709 | 639 | +11.0% |
| Products and Resources · GB | 143 | 143 | 0.0% |
| Products and Resources · North America | 921 | 910 | +1.2% |
| Products and Resources · Rest of World [Member] | 83 | 84 | -1.2% |
| Products and Resources · Time And Materials Contract | 514 | 567 | -9.3% |
| Products and Resources · Transaction Or Volume-Based [Member] | 95 | 89 | +6.7% |
Show Geography breakouts |
|||
| Europe | 1,018 | 939 | +8.4% |
| Europe, excluding United Kingdom [Member] | 538 | 494 | +8.9% |
| GB | 480 | 445 | +7.9% |
| North America | 3,986 | 3,822 | +4.3% |
| Rest of World [Member] | 329 | 321 | +2.5% |
Show — breakouts |
|||
| Revenue | 1,924 | 1,896 | +1.5% |
| Revenue | 441 | 448 | -1.6% |
| Revenue | 104 | 75 | +38.7% |
| Revenue | -898 | -862 | -4.2% |
| Revenue | -983 | -930 | -5.7% |
| Revenue | -1,051 | -1,049 | -0.2% |
| Revenue | -765 | -707 | -8.2% |
| Revenue | 982 | 906 | +8.4% |
| Revenue | -949 | -915 | -3.7% |
| Revenue | 249 | 239 | +4.2% |
| Revenue | 655 | 690 | -5.1% |
| Revenue | 1,924 | 1,896 | +1.5% |
Show Contract With Customer Basis Of Pricing breakouts |
|||
| Fixed Price Contract | 2,640 | 2,359 | +11.9% |
| Time And Materials Contract | 2,203 | 2,255 | -2.3% |
| Transaction Or Volume-Based [Member] | 490 | 468 | +4.7% |
| Operating Expenses (Q) | — | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 34 | 103 | -67.0% |
| Comprehensive Income | 552 | 208 | +165.4% |
| Other Comprehensive Income | -96 | -338 | +71.6% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -10 | -39 | +74.4% |
| Accumulated Other Comprehensive Income | -96 | -338 | +71.6% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,901 | 2,231 | -14.8% |
| Short-Term Investments | 13 | 12 | +8.3% |
| Accounts Receivable | 4,439 | 4,059 | +9.4% |
| Other Assets Current | 1,465 | 1,202 | +21.9% |
| Total Current Assets | 7,818 | 7,504 | +4.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 933 | 994 | -6.1% |
| Operating Lease Right-of-Use Assets | 573 | 552 | +3.8% |
| Goodwill | 7,106 | 6,953 | +2.2% |
Show Business Segments breakouts |
|||
| Communications, Media and Technology | 1,080 | 1,045 | +3.3% |
| Financial Services | 1,177 | 1,129 | +4.3% |
| Health Sciences | 2,915 | 2,895 | +0.7% |
| Products and Resources | 1,934 | 1,884 | +2.7% |
| Deferred Tax Assets | 967 | 1,248 | -22.5% |
| Long Term Investments | 111 | 90 | +23.3% |
| Other Non-Current Assets | 1,767 | 1,026 | +72.2% |
| Total Assets | 20,692 | 19,966 | +3.6% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 1,283 | 1,466 | -12.5% |
| Developed Technology Rights | 8 | 5 | +60.0% |
| Finite lived trademarks and other | 10 | 12 | -16.7% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 1,417 | 1,599 | -11.4% |
| Current Liabilities | |||
| Accounts Payable | 308 | 340 | -9.4% |
| Deferred Revenue | 501 | 450 | +11.3% |
| Operating Lease Liability Current | 153 | 152 | +0.7% |
| Total Current Liabilities | 3,659 | 3,585 | +2.1% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Credit Agreement [Member] · Loans Payable | 33 | 33 | 0.0% |
| Non-Current Liabilities | |||
| Deferred Revenue Noncurrent | 37 | 30 | +23.3% |
| Operating Lease Liabilities | 423 | 420 | +0.7% |
| Deferred Tax Liabilities | 168 | 154 | +9.1% |
| Long-Term Debt | 543 | 875 | -37.9% |
| Other Non-Current Liabilities | 847 | 494 | +71.5% |
| Total Liabilities | 5,677 | 5,558 | +2.1% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Credit Agreement [Member] · Loans Payable | 577 | 610 | -5.4% |
| Other Liabilities | |||
| Short Term Borrowings | 33 | 33 | 0.0% |
| Accrued Liabilities And Other Liabilities | 2,664 | 2,610 | +2.1% |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Additional Paid-In Capital | 12 | 13 | -7.7% |
| Retained Earnings | 15,158 | 14,686 | +3.2% |
| Accumulated Other Comprehensive Income | -160 | -296 | +45.9% |
| Total Stockholders' Equity | 15,015 | 14,408 | +4.2% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss | -109 | -17 | -541.2% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -63 | -25 | -152.0% |
| Accumulated Other Comprehensive Income | -160 | -296 | +45.9% |
| Accumulated Translation Adjustment | 12 | -254 | +104.7% |
| Additional Paid In Capital | 12 | 13 | -7.7% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | 15,158 | 14,686 | +3.2% |
| Total Liabilities & Equity | 20,692 | 19,966 | +3.6% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 140 | 143 | -2.1% |
| Deferred Income Taxes | -88 | -153 | +42.5% |
| Stock-Based Compensation | 44 | 41 | +7.3% |
| Other Non-Cash Items | -2 | 9 | -122.2% |
| Change in Accounts Receivable | -44 | 117 | -137.6% |
| Increase Decrease In Other Operating Assets | -119 | 126 | -194.4% |
| Change in Accounts Payable | 33 | 6 | +450.0% |
| Increase Decrease In Deferred Revenue | 119 | 100 | +19.0% |
| Increase Decrease In Other Operating Liabilities | 127 | -15 | +946.7% |
| Net Cash from Operations | 858 | 920 | -6.7% |
| Investing Activities | |||
| Capital Expenditures | -77 | -83 | +7.2% |
| Payments To Acquire Other Investments | 0 | -1 | +100.0% |
| Proceeds From Sale And Maturity Of Other Investments | 2 | 5 | -60.0% |
| Net Cash from Investing | -75 | -79 | +5.1% |
| Financing Activities | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 12 | 14 | -14.3% |
| Share Repurchases | -338 | -154 | -119.5% |
| Payments Of Dividends Common Stock | -151 | -150 | -0.7% |
| Net Cash from Financing | -487 | -602 | +19.1% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -3 | -21 | +85.7% |
| Net Change in Cash | 293 | 218 | +34.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,634 | 2,231 | +18.1% |
Values in millions USD. Source: SEC EDGAR 10-K filing.